LIPOCINE INC. Operating Loss Carryforwards
LIPOCINE INC. (LPCN) had Operating Loss Carryforwards of $160.80 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Operating Loss Carryforwards $160.80M.
- 2024-12-31: Operating Loss Carryforwards $135.20M.
- 2023-12-31: Operating Loss Carryforwards $138.60M.
- 2022-12-31: Operating Loss Carryforwards $140.00M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $160.80M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $135.20M 10-K · filed 2025-03-13 | |
| 2023-12-31 | $138.60M 10-K · filed 2024-03-07 | |
| 2022-12-31 | $140.00M 10-K · filed 2023-03-10 | |
| 2021-12-31 | $135.60M 10-K · filed 2022-03-09 | |
| 2020-12-31 | $136.70M 10-K · filed 2021-03-11 | |
| 2019-12-31 | $1.30M 10-K · filed 2021-03-11 | $118.90M 10-K · filed 2020-03-13 |
| 2018-12-31 | $1.20M 10-K · filed 2020-03-13 | $106.60M 10-K · filed 2019-03-06 |
| 2017-12-31 | $96.50M 10-K · filed 2018-03-12 | |
| 2016-12-31 | $78.00M 10-K · filed 2017-03-06 | |
| 2015-12-31 | $59.90M 10-K · filed 2016-03-10 | |
| 2014-12-31 | $44.10M 10-K · filed 2015-03-11 | |
| 2013-06-30 | $88.13K 10-Q · filed 2013-07-09 | |
| 2013-03-31 | $85.03K 10-Q · filed 2013-04-24 | |
| 2012-12-31 | $81.82K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |